Company profile: mAbxience
1.1 - Company Overview
Company description
- Provider of biologic products, mainly biosimilar drugs, specializing in research, development and manufacture. Established in Europe in 2009, the multinational biopharmaceutical group operates internationally with a strong presence in major pharmaceutical markets.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to mAbxience
PMG Research
HQ: United States
Website
- Description: Provider of integrated clinical research through a network of facilities operating from 12 U.S. metropolitan areas, conducting trials since 1979. Offerings include Accellacare studies on medical conditions such as migraines, post-surgical neuropathy, and COVID-19 vaccines; The Patient Voice feedback program; Lunch and Learn; and Tell a Friend referral program.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PMG Research company profile →
BioClin Labs
HQ: Ireland
Website
- Description: Provider of internationally recognised expert analytical services and rapid reporting of data to support drug development and product release, leveraging breadth of scientific experience and knowledge across a wide range of techniques to develop optimal methods that run efficiently and meet regulatory.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioClin Labs company profile →
Biomind Labs
HQ: Canada
Website
- Description: Provider of pharmaceutical development for neurological and psychiatric disorders, advancing candidates including BMND01 for treatment-resistant depression, BMND03 for addictive disorders, BMND07 for major depressive disorder, BMND09 for Parkinson’s disease, BMND08 for depression and anxiety in Alzheimer’s disease, and Triptax™, a new chemical entity for treatment-resistant depression with FDA IND clearance.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Biomind Labs company profile →
PHMR
HQ: United Kingdom
Website
- Description: Provider of strategic consulting services to biopharmaceutical, diagnostics, MedTech, and life science companies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PHMR company profile →
Aldevron
HQ: United States
Website
- Description: Provider of contract manufacturing and scientific services in cell and genetic engineering, specializing in plasmid DNA, protein/enzyme production, and antibody generation. Offers plasmid DNA manufacturing (research to clinical), nanoplasmid design/retrofit, mRNA manufacturing and encapsulation, CRISPR nucleases, RNP complexes, and in vitro transcription and capping enzymes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aldevron company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for mAbxience
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to mAbxience
2.2 - Growth funds investing in similar companies to mAbxience
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for mAbxience
4.2 - Public trading comparable groups for mAbxience
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →